Locally Advanced Cancer: Clinical Trials

2 trials for Locally Advanced Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Terminated 1

Follow Locally Advanced Cancer: new trials by email Literature Review of Locally Advanced Cancer trials Research Report on Locally Advanced Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC
FOLFIRI, OSE2101 - Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer
Phase 2Active not recruitingGERCOR - Multidisciplinary Oncology Cooperative Group1062021-04-102025-07-25
Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer
Carboplatin-Paclitaxel adjuvant chemotherapy - Locally Advanced Cancer, Cervical Cancer
Phase 2TerminatedCentre Oscar Lambret212020-07-152026-03-18

Narrower conditions

Neoplasm Metastasis (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Uterine Cervical Diseases (1)  ·  Uterine Diseases (1)  ·  Uterine Neoplasms (1)

Interventions

CP protocol (1)  ·  Chemotherapy, Adjuvant (1)  ·  Fluorouracil (1)  ·  IFL protocol (1)  ·  Irinotecan (1)  ·  Leucovorin (1)

Sponsors

Centre Oscar Lambret (1)  ·  GERCOR - Multidisciplinary Oncology Cooperative Group (1)

Countries

France (2)

Top investigators

Florence Le Tinier, MD (1)

NIH funding

2018 (1)